Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086].

Eur J Med Chem

School of Pharmacy, College of Pharmacy, Taipei Medical University, Taiwan; TMU Biomedical Commercialization Center, Taipei Medical University, Taiwan; Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taiwan. Electronic address:

Published: September 2020

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejmech.2020.112404	DOI Listing

Publication Analysis

corrigendum to"isoindoline

to"isoindoline scaffold-based

scaffold-based dual

dual inhibitors

inhibitors hdac6

hdac6 hsp90

hsp90 suppressing

suppressing growth

growth lung

lung cancer

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!